Schedule 13D ownership disclosure

MARKER THERAPEUTICS INC

Security class unavailable · CUSIP: 57055L206

Event date: 2021-03-16

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
5.4600%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001213900-23-017251
Form type
SC 13D/A
Filer
Aisling Capital IV, LP
CIK
CIK 1652910
Filed
Mar 03, 2023
Reporting period
Mar 16, 2021
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub